1st Circ. Told No Fraud Was Public Before Covidien FCA Suit
A whistleblower claiming a Covidien Ltd. unit tricked Medicare into illegally funding off-label uses for a blood-blocking device told the First Circuit on Monday that the district court's decision to toss...To view the full article, register now.
Already a subscriber? Click here to view full article